Guardian Pharmacy Services Announces Pricing of Upsized Underwritten Public Offering of Class A Common Stock Guardian Pharmacy Services, Inc. today announced the pricing of its upsized underwritten public offering of 6,000,000 shares of its Class A common stock at a public offering price of $31.00 per share, of which 4,980,000 shares will be sold by certain selling stockholders and 1,020,000 shares will be issued and sold by Guardian as part of a non-dilutive“...

#GRDN Guardian Pharmacy Services Announces Pricing of Upsized Underwritten Public Offering of Class A Common Stock

www.stocktitan.net/news/GRDN/guardian-pharm...

Guardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common Stock Guardian Pharmacy Services (NYSE: GRDN) launched a proposed underwritten public offering of 5,000,000 Class A shares on March 18, 2026, including 3,980,000 shares by selling stockholders and 1,020,000 newly issued shares by Guardian.The underwriters have a 30-day option for up to an additional 750,000 shares. Guardian intends a non-dilutive "Synthetic Secondary": net proceeds it receives will be used to repurchase an equal number of Class A shares, keeping total outstanding Class A shares unchanged. A shelf registration on Form S-3 became effective November 3, 2025.

#GRDN Guardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common Stock

www.stocktitan.net/news/GRDN/guardian-pharm...

Guardian Pharmacy Services Reports Fourth Quarter and Full Year 2025 Financial Results; Raises 2026 Adjusted EBITDA Guidance Guardian Pharmacy Services (NYSE: GRDN) reported Q4 2025 revenue of $397.6M (+17% YoY; organic +12%) and Q4 Adjusted EBITDA of $39.5M (+53% YoY). Full-year 2025 revenue was $1.45B (+18%); Adjusted EBITDA $115.1M (+27%); net income $49.0M versus a ($71.0M) loss in 2024. Cash totaled $65.6M at year-end. The company raised 2026 Adjusted EBITDA guidance to $120M–$124M while maintaining the prior 2026 revenue outlook of $1.40B–$1.42B. Operational highlights included one acquisition, improved vaccine profitability, and ~205,000 residents served at year-end.

#GRDN Guardian Pharmacy Services Reports Fourth Quarter and Full Year 2025 Financial Results; Raises 2026 Adjusted EBITDA Guidance

www.stocktitan.net/news/GRDN/guardian-pharm...

Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026, at 4:30 p.m. PT. Guardian is reiterating its previously announced 2025 revenue guidance of $1.43 billion to $1.45 billion and adjusted EBITDA guidance of $104 million to $106 million. For 2026, Guardian expects revenue in the range of $1.40 billion to $1.42 billion, after the...

#GRDN Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook

www.stocktitan.net/news/GRDN/guardian-pharm...

With AI valuations stretched, five small caps to look at into the year-end – Oninvest By the end of this year, interest in small caps is picking up as investors confront an overheated tech sector and increasingly concentrated, outstripping growth by a handful of AI stocks. According to...

Rate cuts, attractive valuations, and improving fundamentals make small-caps in areas like defense, climate services, IT distribution and healthcare worth a fresh look. Names to watch: #RCAT, #PRM, #CLMB, #GRDN, #ATRO. Details👇 en.oninvest.com/article/with...

#GRDN Guardian Pharmacy Services Reports Third Quarter 2025 Financial Results; Raises Full-Year Guidance

www.stocktitan.net/news/GRDN/guardian-pharm...

Guardian Pharmacy Services Announces Filing of S-3 Shelf Registration Statement and Lock-up Agreements with Pre-IPO Holders of Class A Common Stock Guardian Pharmacy Services, Inc., one of the nation’ s leading long-term care pharmacy services companies, today announced that it has filed a shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission. The registration statement relates to the possible issuance and sale of up to 1,020,000 shares of Class A common stock by...

#GRDN Guardian Pharmacy Services Announces Filing of S-3 Shelf Registration Statement and Lock-up Agreements with Pre-IPO Holders of Class A Common Stock

www.stocktitan.net/news/GRDN/guardian-pharm...

particles, coarse by GRDN. With particles, coarse GRDN. continues his deliberate journey toward the outer edges of electronic sound.

The album thrives on a raw, glitch-infused, and organically textured sonic language that deliberately rejects conventional song structures. #music #grdn #particles #coarse #album #wanderingastray

EHFM Edinburgh Community Radio Club Night | The Gilded Saloon | Tickets | SESH.sx Event details coming soon.

EHFM Edinburgh Community Radio Club Night @ The Gilded Saloon - 17 Aug feat. GRDN, Ravelston, aminabonthebeat

#SESH #GRDN #Ravelston #aminabonthebeat

Guardian Pharmacy Services Reports Second Quarter 2025 Financial Results; Raises Full-Year Guidance Guardian Pharmacy Services (NYSE:GRDN) reported strong Q2 2025 financial results, with revenue increasing 15% year-over-year to $344.3 million. The company's resident count grew 12% to over 195,000, while Adjusted EBITDA reached $25.0 million.The company expanded its footprint through strategic acquisitions in Wichita, KS and Seattle, WA, launched a new greenfield pharmacy in Naples, FL, and subsequently acquired Managed Healthcare Pharmacy in Oregon. Guardian also completed a non-dilutive secondary offering of 8.625 million shares, enhancing trading liquidity.Based on strong H1 2025 performance, Guardian raised its full-year guidance, projecting revenue of $1.39-1.41 billion (up from $1.33-1.35 billion) and Adjusted EBITDA of $100.0-102.0 million (up from $97.0-101.0 million).

#GRDN Guardian Pharmacy Services Reports Second Quarter 2025 Financial Results; Raises Full-Year Guidance

www.stocktitan.net/news/GRDN/guardian-pharm...

Guardian Pharmacy Services Announces Pricing of Underwritten Public Offering of Class A Common Stock Guardian Pharmacy Services (NYSE: GRDN) has announced the pricing of its underwritten public offering of 7.5 million shares of Class A common stock at $21.00 per share. The offering consists of 6,059,553 shares from selling stockholders and 1,440,447 shares from Guardian in a non-dilutive synthetic secondary transaction. The underwriters have a 30-day option to purchase an additional 1,125,000 shares.The offering, expected to close on May 27, 2025, is structured as non-dilutive since Guardian will use all net proceeds to repurchase 1,440,447 shares of Class A common stock at the offering price less underwriting discount. The total number of outstanding shares will remain unchanged after completion. Raymond James leads the offering as bookrunning manager, with Stephens Inc. and Truist Securities as joint bookrunning managers.

#GRDN Guardian Pharmacy Services Announces Pricing of Underwritten Public Offering of Class A Common Stock

www.stocktitan.net/news/GRDN/guardian-pharm...

Guardian Pharmacy Announces Major 7.5M Share Offering: Key Details of Non-Dilutive Structure Revealed Guardian Pharmacy unveils 7.5M share public offering with unique non-dilutive structure. Raymond James leads the underwriting. See full transaction details.

#GRDN Guardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common Stock

www.stocktitan.net/news/GRDN/guardian-pharm...

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with bearish moving average convergence divergence crossovers, Tue May 13th - #ZTEK #VTYX #TALK #SATL #RLAY #PHVS #OTLY #LWAY #KPTI #INZY #IIIV #HITI #GAIA #ERAS #DOYU #AUPH #UVV #LTC #GRDN #CGAU - More: crystalequityresearch.com/SmCpStr/ - #smallcap

Guardian Pharmacy Services, Inc. Reports First Quarter 2025 Financial Results Guardian Pharmacy Services (NYSE: GRDN) reported strong Q1 2025 financial results, with revenue reaching $329.3 million, up 20% year-over-year. The company's resident count increased 15% to 189,000, while net income grew by $2.2 million to $9.3 million. Adjusted EBITDA rose 16% to $23.4 million.The growth was driven by organic expansion and recent acquisitions, including Heartland Pharmacy and Freedom Pharmacy. Guardian completed another acquisition in Wichita, Kansas on April 1, 2025, bringing its total pharmacy count to 52. The company maintains a strong financial position with $14.0 million in cash and no long-term debt.Guardian reaffirmed its 2025 guidance, expecting revenue between $1.330-1.350 billion and Adjusted EBITDA of $97-101 million.

#GRDN Guardian Pharmacy Services, Inc. Reports First Quarter 2025 Financial Results

www.stocktitan.net/news/GRDN/guardian-pharm...

Guardian Pharmacy Delivers Record $1.2B Revenue, Projects Strong 2025 Growth Q4 shows 30% EBITDA growth and 14% resident growth to 186,000. Strong 2025 guidance projects revenue up to $1.35B. See full financial analysis and growth drivers.

#GRDN Guardian Pharmacy Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

www.stocktitan.net/news/GRDN/guardian-pharm...

Guardian Pharmacy's Revenue Jumps 20.5% in Q4: Can Their Growth Momentum Continue in 2025? Guardian Pharmacy achieved $338.6M in Q4 revenue (+20.5% YoY) despite IPO-related expenses. 2025 guidance projects continued growth with $1.33-1.35B revenue target.

#GRDN Guardian Pharmacy Services, Inc. Announces Preliminary Fourth Quarter and Full Year 2024 Results; Provides 2025 Financial Guidance and Earnings Conference Call Date

www.stocktitan.net/news/GRDN/guardian-pharm...

Daun EP by GRDN. The upcoming Daun EP by GRDN marks a stunning addition to the ambient and electronica music landscape.

The upcoming Daun EP by GRDN marks a stunning addition to the ambient and electronica music landscape. #music #grdn #daun #wanderingastray